B.R.I.D.G.E. TO DATA®
"Kidz with Leukemia: A Space Adventure"
"Conquering Cancer Network"
The Degge Group, Ltd. provides consulting services in pharmacoepidemiology, risk management, clinical drug safety, and pharmacovigilance to the pharmaceutical and medical product sector.
Degge's staff has contributed to the burgeoning fields of pharmacoepidemiology and pharmacovigilance for over two decades and has worked to enhance the understanding of drug safety, drug use, natural history of disease, pharmacoeconomic and outcomes research, and recently risk evaluation and mitigation strategies (REMS).
Degge will help you identify and analyze key factors and find the right solution.
- Degge celebrates its 25th Anniversary of consulting in Drug Safety Research and Pharmacoepidemiology.
Dr. Judith K. Jones and Degge colleagues recently published an article in The Chinese Jnl of Pharmacoepidemology.
(May 2013), a key journal in China since 1992. This article, entitled "Pre-marketing drug safety risk management in the pharmaceutical industry",
discusses the vital need to integrate pharmacovigilance and risk management strategies into pre-marketing pharmaceutical development from concept through market authorization, regardless of where the drug is developed. This article has applications in China, the US, and worldwide.
For more information, please contact us at email@example.com
- Congratulations to Dawn Kim-Romo, PharmD for
being awarded the PhRMA Foundation's Pre-Doctoral
Fellowship in Health Outcomes. Dawn was a star intern at The Degge Group, Ltd.
in the Summer of 2012, and she is currently a PhD candidate at the University of
Texas, Austin (as well as a practicing pharmacist). We take no credit for Dawn's
success, but are simply proud to be associated with such a motivated professional!
Degge' formal internship program has had the good fortune to train graduate and professional students in pharmacoepidemiology and drug safety for nearly 10 years.
Here's more info on our internship.
Dr. Judith K. Jones of The Degge Group, Ltd. will be teaching the Pharmacoepidemiology and Risk Management Course (Epid 722) at the University of Michigan’s School of Public Health this summer (July 22-26, 2013). As Adjunct Professor of Epidemiology, she will cover adverse events as a major public health problem and the more recent implementation of pharmaceutical risk management plans or Risk Evaluation and Mitigation Strategies (REMS). Also covered are epidemiologic methods and resources (e.g., the Sentinel System) to study the use and effects of biopharmaceuticals, devices, and other medical products.
For more information on this and other related courses, and to register, CLICK HERE for more details.
The Degge Group, Ltd.
clinical drug safety, pharmacovigilance, and pharmacoepidemiology since 1988.
1616 North Fort Myer Drive, Suite 1430
Arlington, Virginia 22209 USA
1 (888) 413-3443
Phone: +1 (703) 276-0067 || Fax: +1 (703) 276-0069